David Harrington

Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer

Joan H. Schiller, David Harrington, Chandra P. Belani et al. · New England Journal of Medicine · 2002 · 4.9K citations

Clinical and biologic implications of recurrent genomic aberrations in myeloma

Rafaël Fonseca, Emily Blood, Montserrat Rué et al. · Blood · 2003 · 658 citations

The Design and Analysis of Sequential Clinical Trials.

David Harrington, John Whitehead · Journal of the American Statistical Association · 1985 · 638 citations

Health Policy, Clinical Trial Management, Clinical Trial Analysis +14

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients

Rafaël Fonseca, Emily Blood, Martin M. Oken et al. · Blood · 2002 · 337 citations

Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma

Leo I. Gordon, David Harrington, Janet Andersen et al. · New England Journal of Medicine · 1992 · 326 citations · Full text